53
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Epstein – Barr Virus Positive Large B-Cell Lymphoma Arising in a Patient Previously Treated with Cladribine for Hairy Cell Leukemia

, , &
Pages 1043-1048 | Received 16 Sep 2003, Published online: 03 Aug 2009

References

  • Jaffe, E., Harris, N., Stein, H., Vardiman, J. (2001) "Pathology and genetics of tumours of haematopoietic and lymphoid tissues". In World Health Organization Classification of Tumours edited by P. Kleihues and L. Sobin. Lyon, France: IARC Press.
  • Kamel, 0.W., Weiss, L.M., van de Rijn, M., Colby, T.V., Kingma, D.W. and Jaffe, E.S. (1996) "Hodgkin's disease and lymphoproli-ferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy", American Journal of Surgical Pathology, 20, 1279 — 1287.
  • Sibilia, J., Liote, F. and Mariette, X. (1998) "Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrex-ate", Revue Du Rhumatisme [Engl Ed], 65, 267 — 273.
  • Tournadre, A., D'Incan, M., Dubost, ii., Franck, F., Dechelotte, P., Souteyrand, P., et al. (2001) "Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate", Mayo Clinic Proceedings, 76, 845–848.
  • Dawson, T.M., Starkebaum, G., Wood, B.L., Willkens, R.F. and Gown, A.M. (2001) "Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjogren's syndrome: case series", The Journal of Rheumatology, 28, 47 — 53.
  • Mariette, X., Cazals-Hatem, D., Warszawki, J., Liote, F., Balan-draud, N. and Sibilia, J. (2002) "Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France", Blood, 99, 3909–3915.
  • Kamel, 0.W., van de Rijn, M., Weiss, L.M., Del Zoppo, G.J., Hench, P.K., Robbins, BA., et al. (1993) "Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyosi-tis", New England Journal of Medicine, 328, 1317 — 1321.
  • Viraben, R., Brousse, P. and Lamant, L. (1996) "Reversible cutaneous lymphoma occurring during methotrexate therapy", British Journal of Dermatology, 135, 116 — 118.
  • Le Goff, P., Chicault, P., Saraux, A., Baron, D., Valls-Bellec, I. and Leroy, J.P. (1998) "Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus", Revue Du Rhumatisme [Engl Ed], 65, 283–286.
  • Moseley, AC., Lindsley, H.B., Skikne, B.S. and Tawfik, 0. (2000) "Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease", The Journal of Rheumatology, 27, 810–813.
  • Van Den Neste, E., Delannoy, A., Vandercam, B., Bosly, A., Ferrant, A., Mineur, P., et al. (1996) "Infectious complications after 2-chlorodeoxyadenosine therapy". European Journal of Haematol-ogy, 56, 235–240.
  • Anaissie, E.J., Kontoyiannis, D.P., O'Brien, S., Kantarjian, H., Robertson, L., Lerner, S., et al. (1998) "Infections in patients with chronic lymphocytic leukemia treated with fludarabine", Annals of Internal Medicine, 129, 559–566.
  • Van Den Neste, E., Delannoy, A., Feremans, W., Ferrant, A. and Michaux, L. (2001) "Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treat-ment", Leukemia and Lymphoma, 40, 541 — 550.
  • Abruzzo, L.V., Rosales, CM., Medeiros, Li., Vega, F., Luthra, R., Manning, J.T., et al. (2002) "Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neo-plasms", American Journal of Surgical Pathology, 26, 630 — 636.
  • Niesvizky, R., Zhu, AX., Louie, D. and Michaeli, J. (1999) "Epstein-Barr virus-associated lymphoma after treatment of macro-globulinemia with cladribine", New England Journal of Medicine, 341, 55.
  • Rubin, D., Hudnall, S.D., Aisenberg, A., Jacobson, J.0. and Harris, N.L. (1994) "Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection", Modern Pathology, 7, 91— 98.
  • Shields, DJ., Byrd, J.C., Abbondanzo, S.L., Lichy, J.H., Diehl, L.F. and Aguilera, N.I. (1997) "Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment", Modern Pathology, 10, 1151 — 1159.
  • Raab-Traub, N. and Flynn, K. (1986) "The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular prolifera-tion", Cell, 47, 883–889.
  • Friedline, J.A., Crisan, D. and Chen, J. (1998) "Blastic Transforma-tion in a Case of Hairy Cell Leukemia", Molecular Diagnosis, 3, 163 — 169.
  • Nazeer, T., Burkart, P., Dunn, H., Jennings, T.A. and Wolf, B. (1997) "Blastic transformation of hairy cell leukemia", Archives of Pathology and Laboratory Medicine, 121, 707–713.
  • Huang, AT., Silverstein, L., Gonias, S.L., Rundles, R.W. and Raab-Traub, N. (1987) "Transformation of hairy cell leukemia to EBV genome-containing aggressive B cell lymphoma", Leukemia, 1, 369 — 372.
  • Sakamoto, K., Aiba, M., Katayama, I., Sullivan, J.L., Humphreys, RE. and Purtilo, D.T. (1981) "Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia", International Journal of Cancer, 27, 453–458
  • Wolf, B.C., Martin, A.W., Neiman, R.S., Janckila, A.J., Yam, L.T., Caracansi, A., et al. (1990) "The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridisation", Amerian Journal of Pathology, 136, 717 — 723.
  • Chang, K.L., Chen, Y.Y. and Weiss, L.M. (1993) "Lack of evidence of Epstein-Barr virus in hairy cell leukemia and monocytoid B-cell lymphoma", Human Pathology, 24, 58–61.
  • Sairenji, T., Spiro, R.C., Reisert, P.S., Paquin, L., Sakamoto, K., Shibuya, A., et al. (1983) "Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia", American Journal of Hematology, 15, 361 — 374.
  • Sairenji, T., Reisert, P.S., Spiro, R.C., Mulder, C. and Humphreys, R.E. (1983) "Restrictions upon Epstein-Barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia", Hematological Oncology, 1, 251— 262.
  • Robak, T. (2001) "Cladribine in the treatment of chronic lymphocytic leukemia" Leukemia and Lymphoma, 40, 551— 564.
  • Raspadori, D., Rondelli, D., Birtolo, S., Lenoci, M., Nardi, G., Scalia, G., et al. (1999) "Long-lasting decrease of CD4 + / CD45RA + T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment", Leukemia, 13, 1254 — 1257.
  • Bastie, J.N., Cazals-Hatem, D., Daniel, MT., D'Agay, M.F., Rabian, C., Glaisner, S., et al. (1999) "Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4 + lymphocytopenia after treatment", Leukemia and Lymphoma, 35, 555 — 565.
  • Kamel, 0.W., van de Rijn, M., LeBrun, D.P., Weiss, L.M., Warnke, R.A. and Dorfman, R.F. (1994) "Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosup-pression", Human Pathology, 25, 638–643.
  • Kamel, 0.W., van de Rijn, M., Hanasono, M.M. and Warnke, R.A. (1995) "Immunosuppression-associated lymphoproliferative disor-ders in rheumatic patients", Leukemia and Lymphoma, 16, 363–368.
  • Kamel, 0.W. (1997) "Iatrogenic lymphoproliferative disorders in nontransplantation settings", Seminars in Diagnostic Pathology, 14, 27 — 34.
  • Kamel, 0.W. (1997) "Lymphomas during long-term methotrexate therapy", Arch Dermatol, 133, 903–904.
  • Salloum, E., Cooper, DL., Howe, G., Lacy, J., Tallini, G., Crouch, J., et al. (1996) "Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases", Journal of Clinical Oncology, 14, 1943–1949.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.